CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-In Capital	Retained Earnings	Total
Beginning balance, shares at Aug. 31, 2015	16,943,001
Beginning balance, value at Aug. 31, 2015	$ 5,414	$ 9,714,290	$ 9,812,498	$ 19,532,202
Exercise of stock options, shares	112,463
Exercise of stock options, amount	$ 113	$ 181,936		182,049
Stock-based compensation		347,077		347,077
Issuance of stock - Cognigen acquisition, shares	170,014
Issuance of stock - Cognigen acquisition, value	$ 1,700	1,132,704		1,134,404
Declaration of dividends			(3,413,274)	(3,413,274)
Net income			4,950,136	4,950,136
Ending balance, shares at Aug. 31, 2016	17,225,478
Ending balance, value at Aug. 31, 2016	$ 7,227	$ 11,376,007	$ 11,349,360	22,732,594
Exercise of stock options, shares	49,642
Exercise of stock options, amount	$ 49	$ 111,355		111,404
Stock-based compensation		585,018		585,018
Shares issued to Directors for services, shares	2,484
Shares issued to Directors for services, value	$ 2	36,761		36,763
Declaration of dividends			$ (3,448,489)	(3,448,489)
Net income			5,787,597	5,787,597
Ending balance, shares at Aug. 31, 2017	17,277,604
Ending balance, value at Aug. 31, 2017	$ 7,278	$ 12,109,141	$ 13,688,468	25,804,887
Exercise of stock options, shares	130,006
Exercise of stock options, amount	$ 131	$ 635,452		635,583
Stock-based compensation		$ 562,078		562,078
Shares issued to Directors for services, shares	8,835
Shares issued to Directors for services, value	$ 8	$ 146,997		147,005
Declaration of dividends			$ (4,161,740)	(4,161,740)
Net income			8,934,812	8,934,812
Ending balance, shares at Aug. 31, 2018	17,416,445
Ending balance, value at Aug. 31, 2018	$ 7,417	$ 13,453,668	$ 18,461,540	$ 31,922,625